>
Big Tech Dominance Ties to Technocracy Agenda...
ITALIAN RESTAURANTS DEMAND "LIBERTÁ" FROM LOCKDOWNS
Peter Thiel bought an $18 million island estate in Miami that was once featured on MTV's...
The New Domestic War on Terror is Coming
Autonomous Flight unveils six-seat eVTOL tricopter air shuttle
Full Autonomous Self Driving Teslas in Vegas Boring Tunnels by the End of 2021
Fish-inspired robots coordinate movements without any outside control
The UK Is Developing Nuclear-Powered Space Exploration for Faster Mars Trips
GM Unveils Cadillac Flying Car For Rich People
Gigafactories With New Solar PV Module Tech Might Cause Solar Glut in 2021
Orbital Assembly Building Parts to Eventually Scale to Large Rotating Space Stations
GM Unveils Cadillac Flying Car For Rich People
How Phoenix Feeds The Hungry With Fresh Food While Saving Local Businesses and Farms
Oak Ridge Research Next Generation Cathode Free Lithium Ion Batteries
Just a few doses of an experimental drug that reboots protein production in cells can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists.
The drug, called ISRIB, has already been shown in laboratory studies to restore memory function months after traumatic brain injury (TBI), reverse cognitive impairments in Down Syndrome, prevent noise-related hearing loss, fight certain types of prostate cancer, and even enhance cognition in healthy animals.
In the new study, published Dec. 1 in the open-access journal eLife, researchers showed rapid restoration of youthful cognitive abilities in aged mice, accompanied by a rejuvenation of brain and immune cells that could help explain improvements in brain function—and with no side effects observed.
"ISRIB's extremely rapid effects show for the first time that a significant component of age-related cognitive losses may be caused by a kind of reversible physiological "blockage" rather than more permanent degradation," said Susanna Rosi, PhD, Lewis and Ruth Cozen Chair II and professor in the departments of Neurological Surgery and of Physical Therapy and Rehabilitation Science.
"The data suggest that the aged brain has not permanently lost essential cognitive capacities, as was commonly assumed, but rather that these cognitive resources are still there but have been somehow blocked, trapped by a vicious cycle of cellular stress," added Peter Walter, PhD, a professor in the UCSF Department of Biochemistry and Biophysics and a Howard Hughes Medical Institute investigator. "Our work with ISRIB demonstrates a way to break that cycle and restore cognitive abilities that had become walled off over time."